UPDATED Mar 14, 2024
Stocks with a market cap under US$50M.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
VY3 | CA$0.016 | -27.3% | n/a | CA$357.1k | n/a | PE-0.02x | n/a | n/a | Pharmaceuticals & Biotech | ||
VY3 | CA$0.01 | 11.1% | n/a | CA$357.1k | n/a | PE-0.02x | n/a | n/a | Pharmaceuticals & Biotech | ||
CD0 | CA$0.007 | -46.2% | -6.7% | CA$323.8k | n/a | PB0.2x | n/a | n/a | Pharmaceuticals & Biotech | ||
M8H0 | €0.048 | 0% | -97.8% | €194.3k | n/a | PB0.002x | n/a | 0% | Capital Goods | ||
M8H0 | €0.04 | 0% | -96.7% | €194.3k | n/a | PB0.002x | n/a | 0% | Capital Goods | ||
EO7 | US$0.01 | -33.3% | -93.7% | US$188.2k | n/a | PE-0.00008x | n/a | n/a | Pharmaceuticals & Biotech | ||
2PK0 | €0.74 | -0.3% | -99.4% | €158.6k | n/a | PB0.07x | n/a | n/a | Telecom | ||
SD1 | €0.01 | 0% | -95.7% | €148.2k | n/a | n/a | n/a | 400.0% | Media | ||
A3CSRJ | CA$0.10 | 0% | -25.0% | CA$152.3k | n/a | PE-0.9x | n/a | n/a | Commercial Services | ||
YAB | CA$0.059 | -10.0% | 14.7% | CA$152.3k | n/a | PE-0.9x | n/a | n/a | Commercial Services | ||
GWI2 | €0.02 | 0% | -99.7% | €25.0k | n/a | PB0.0009x | n/a | 0% | Consumer Durables | ||
GPQ2 | US$0.001 | -33.3% | -99.9% | US$2.7k | n/a | PE-0.00004x | n/a | 0% | Capital Goods | ||
NST | €0.001 | 0% | n/a | €1.7k | n/a | PB0.0002x | n/a | n/a | Capital Goods |